HARBERT FUND ADVISORS, INC. - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 60 filers reported holding ENZO BIOCHEM INC in Q4 2021. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.

Quarter-by-quarter ownership
HARBERT FUND ADVISORS, INC. ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2023$7,246,278
-23.9%
5,175,9130.0%5.30%
-0.7%
Q2 2023$9,523,680
-24.3%
5,175,9130.0%5.34%
-35.8%
Q1 2023$12,577,469
+69.9%
5,175,9130.0%8.31%
+40.2%
Q4 2022$7,401,556
-35.9%
5,175,9130.0%5.93%
-3.2%
Q3 2022$11,542,000
+7.7%
5,175,9130.0%6.13%
+17.6%
Q2 2022$10,714,000
-28.6%
5,175,9130.0%5.21%
-17.2%
Q1 2022$15,010,000
-9.7%
5,175,9130.0%6.29%
+50.3%
Q4 2021$16,615,000
-9.3%
5,175,9130.0%4.19%
-35.6%
Q3 2021$18,323,000
+11.7%
5,175,9130.0%6.51%
-28.9%
Q2 2021$16,407,000
-7.9%
5,175,9130.0%9.16%
+9.0%
Q1 2021$17,805,000
+25.7%
5,175,913
-7.9%
8.40%
-21.7%
Q4 2020$14,164,000
+19.4%
5,620,6810.0%10.73%
-26.0%
Q3 2020$11,860,000
-5.8%
5,620,6810.0%14.49%
+1.1%
Q2 2020$12,591,000
-11.5%
5,620,6810.0%14.34%
-39.7%
Q1 2020$14,220,000
-3.8%
5,620,6810.0%23.77%
+20.4%
Q4 2019$14,782,000
-26.9%
5,620,6810.0%19.75%
-34.4%
Q3 2019$20,234,000
+16.2%
5,620,681
+8.7%
30.10%
+18.1%
Q2 2019$17,420,000
+110.4%
5,169,337
+70.4%
25.49%
+213.1%
Q1 2019$8,281,000
+85.6%
3,033,641
+89.0%
8.14%
+78.9%
Q4 2018$4,461,0001,605,0004.55%
Other shareholders
ENZO BIOCHEM INC shareholders Q4 2021
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,436,771$7,822,00010.43%
VIEX Capital Advisors, LLC 1,736,087$5,573,0008.96%
HARBERT FUND ADVISORS, INC. 5,175,913$16,615,0004.19%
AMH Equity Ltd 596,742$1,916,0002.66%
Potomac Capital Management, Inc. 208,000$668,0000.59%
Agate Pass Investment Management, LLC 24,292$78,0000.05%
RBF Capital, LLC 250,359$804,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$82,0000.05%
Corsair Capital Management 58,657$188,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 319,500$1,026,0000.02%
View complete list of ENZO BIOCHEM INC shareholders